首页> 外文OA文献 >SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

【2h】

SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

机译：SGN-LIV1A：靶向LIV-1的新型抗体 - 药物缀合物，用于治疗转移性乳腺癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Django Sussman; Leia M. Smith; Martha E. Anderson; Steve Duniho; Joshua H. Hunter; Heather Kostner; Jamie B. Miyamoto; Albina Nesterova; Lori Westendorf; Heather A. Van Epps; Nancy Whiting; Dennis R. Benjamin;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer [J] . Sussman Django, Smith Leia M., Anderson Martha E., Molecular cancer therapeutics . 2014,第12期

机译：SGN-LIV1A：靶向LIV-1的新型抗体-药物偶联物，用于治疗转移性乳腺癌
2. A phase 1 study of ARX788, a HER2-targeting antibody-drug conjugate, in patients with metastatic HER2-positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：ARX788，ARX788，一种靶向抗体 - 药物缀合物，转移HER2阳性乳腺癌患者的阶段1研究
3. Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: Clinical implications of the effect of covariates [J] . LuD., GirishS., GaoY., Cancer chemotherapy and pharmacology. . 2014,第2期

机译：曲妥珠单抗Emtansine（T-DM1）（一种靶向HER2的抗体-药物结合物）在HER2阳性转移性乳腺癌患者中的群体药代动力学：协变量作用的临床意义
4. Mimicking Platelet-Cancer Cell Interactions for Targeted Drug Delivery in Metastatic Breast Cancer [C] . C. Modery-Pawlowski, A. Master, V. Pan, Society for Biomaterials annual meeting and exposition . 2013

机译：模拟转移性乳腺癌中靶向药物递送的血小板-癌细胞相互作用。
5. Design and Evaluation of Peptidomimetics and Peptidomimetics Drug Conjugates Targeting HER2 Overexpressing Cells in Breast and Lung Cancers [D] . Pallerla, Sandeep. 2017

机译：拟肽和拟肽药物结合物靶向乳腺癌和肺癌中HER2过表达细胞的设计和评估
6. Population pharmacokinetics of trastuzumab emtansine (T-DM1) a HER2-targeted antibody–drug conjugate in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates [O] . Dan Lu, Sandhya Girish, Yuying Gao, -1

机译：曲妥珠单抗Emtansine（T-DM1）（一种靶向HER2的抗体-药物偶联物）在HER2阳性转移性乳腺癌患者中的群体药代动力学：协变量作用的临床意义
7. Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results from a phase I/II trial [O] . K. Yonemori, N. Masuda, S. Takahashi, 2019

机译：U3-1402的单药活性，HER3靶向抗体 - 药物缀合物，在HER3过度抑制的转移性乳腺癌中：I / II阶段试验的更新结果

SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅